Contrast agent developer E-Z-EM reported revenues of $26.3 million in its 2001 fiscal second quarter, down 6.1% compared with the $28 million posted in its 2000 fiscal second quarter. For the period (end-December 2), the Westbury, NY-based vendor had net earnings of $861,000, compared with net earnings of $1.8 million last year. Results from the company’s diagnostic segment were adversely impacted by soft demand, both in the U.S. and internationally, according to president and CEO Anthony Lombardo.
By AuntMinnie.com staff writersJanuary 17, 2001
Related Reading
E-Z-EM inks European deal with Nycomed-Amersham, December 18, 2000
E-Z-EM reports flat Q1, October 13, 2000
E-Z-EM turns in record net sales in fiscal 2000, August 7, 2000
Copyright © 2001 AuntMinnie.com
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
